Protracted COVID-19 pneumonia in B-cell-depleted patients
Key message: B cell-depleted patients carry a unique protracted COVID-19 risk, requiring strong suspicion and aggressive treatment.
Authors
- Anushya Jeyabalan (ORCID: https://orcid.org/0000-0003-1959-0250)
- James Chung (ORCID: https://orcid.org/0000-0002-9775-0208)
- John L. Niles (ORCID: https://orcid.org/0009-0003-4072-6535)
- Orhan Efe (ORCID: https://orcid.org/0000-0003-4852-9061)
- Gabriel Sauvage (ORCID: https://orcid.org/0000-0001-9485-491X)
- Karen Laliberte (ORCID: https://orcid.org/0009-0003-0223-2796)
- Ayman Al Jurdi (ORCID: https://orcid.org/0000-0002-7652-3399)
- Harish Seethapathy (ORCID: https://orcid.org/0000-0002-1171-1022)
Institutions
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1093/rheumatology/keae703
- Citations
- 2
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.78